Stenbolone
Appearance
Clinical data | |
---|---|
Other names | 2-Methyl-5α-androst-1-en-17β-ol-3-one; 2-Methyl-δ1-4,5α-dihydrotestosterone; 2-Methyl-δ1-DHT; Deacetylanatrofin |
Routes of administration | Intramuscular injection (as stenbolone acetate) |
Drug class | Androgen; Anabolic steroid |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEBI | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C20H30O2 |
Molar mass | 302.458 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Stenbolone is an anabolic–androgenic steroid (AAS) of the dihydrotestosterone (DHT) group which was never marketed.[1][2][3][4] A C17β ester prodrug of stenbolone, stenbolone acetate, is used as an AAS for depot intramuscular injection under the brand names Anatrofin and Stenobolone.[1][3]
Chemistry
[edit]Stenbolone, also known as 2-methyl-δ1-4,5α-dihydrotestosterone (2-methyl-δ1-DHT) or as 2-methyl-5α-androst-1-en-17β-ol-3-one, is a synthetic androstane steroid and a derivative of DHT.[1][3] It is closely related structurally to drostanolone (2-methyl-DHT), 1-testosterone (δ1-DHT), and methylstenbolone (17α-methylstenbolone).[5]
Society and culture
[edit]Generic names
[edit]Stenbolone is the generic name of the drug and its INN .[1][3][4]
References
[edit]- ^ a b c d Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 1–. ISBN 978-1-4757-2085-3.
- ^ William Llewellyn (2011). Anabolics. Molecular Nutrition Llc. pp. 301–. ISBN 978-0-9828280-1-4.
- ^ a b c d Index Nominum 2000: International Drug Directory. Taylor & Francis. January 2000. pp. 962–. ISBN 978-3-88763-075-1.
- ^ a b Morton IK, Hall JM (6 December 2012). Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer Science & Business Media. pp. 261–. ISBN 978-94-011-4439-1.
- ^ Rahnema CD, Crosnoe LE, Kim ED (2015). "Designer steroids - over-the-counter supplements and their androgenic component: review of an increasing problem". Andrology. 3 (2): 150–5. doi:10.1111/andr.307. PMID 25684733. S2CID 6999218.